Examination of the mediastinal lymph node using the MRI

Examination of the mediastinal lymph node using the MRI - Examination of the mediastinal lymph node using the MRI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032217

Enrollment

Registered

2018-04-12

Start date

2018-04-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mediastinal lymphadenopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with plan pathologically diagnosed in surgery and bronchial robustness in the patients that a mediastinal lymph node is enlarged. 20 years old or older The patients that an agreement is obtained in a document from subjects about study entry.

Exclusion criteria

Exclusion criteria: MRI is the patient of contraindication The patients that an agreement is not obtained The patients that clinical trials responsibility physician or an allotment physician judges participation in this study to be inadequate

Design outcomes

Primary

Measure	Time frame
1) The primary outcome is ADCmap of the MRI in the mediastinal lymph node evaluation and usability of the value. 2) The examination of an ADCmap level and the Erastus graph level obtained under a bronchoscope echo. 3) We examine it whether there are not other useful MRI images.	—

Countries

Japan

Contacts

Public ContactNishimoto Eriko

St. Marianna University School of Medicine Hospital Respiratory internal medicine

e2koda@marianna-u.ac.jp044-977-8111

Outcome results